CYNO Cynosure - Class A (MM)

WESTFORD, Mass., Sept. 10 /PRNewswire-FirstCall/ -- Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that the company will present at the First Annual Maxim Group Growth Conference in New York City. Chief Financial Officer Timothy Baker will discuss Cynosure's business outlook, growth strategy and recent financial results in a presentation beginning at 1:30 p.m. ET Thursday, September 20. The conference will be held at the Grand Hyatt New York Hotel. Investors interested in listening to the live webcast of this presentation should log on to the "Investor Relations" section of Cynosure's website, http://www.cynosure.com/ , and click on the link labeled "Events." The presentation will be archived on the company's website. The Maxim Group Growth Conference will feature interactive presentations from over 70 companies, as well as one-on-one meetings with executives from the healthcare, technology, and special situations sectors. Attendees will include securities analysts, fund managers and institutional investors. About Maxim Group Maxim Group is a leading investment banking, securities and investment management firm. The Firm provides an array of financial services including: investment banking, equity research, private wealth management, structured products, and global institutional equity, fixed-income and derivative sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals. Maxim Group is registered as a broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: National Association of Securities Dealers (NASD); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); International Securities Exchange (ISE); NASDAQ Stock Market; and NYSE Arca, Inc. For additional information, please visit http://www.maximgrp.com/ . About Cynosure, Inc. Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit http://www.cynosure.com/ . Contact Scott Solomon Vice President Sharon Merrill Associates, Inc. 617-542-5300 DATASOURCE: Cynosure, Inc. CONTACT: Scott Solomon, Vice President of Sharon Merrill Associates, Inc., +1-617-542-5300, , for Cynosure, Inc. Web site: http://www.cynosure.com/ http://www.maximgrp.com/

Copyright